Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents.
Corinde E WiersLeandro F VendruscoloJan-Willem van der VeenPeter ManzaEhsan Shokri-KojoriDanielle S KrollDana E FeldmanKatherine L McPhersonCatherine L BieseckerRui ZhangKimberly HermanSophie K ElvigJanaina C M VendruscoloSara A TurnerShanna YangMelanie L SchwandtDardo TomasiMackenzie C CervenkaAnders Fink-JensenHelene BenvenisteNancy DiazgranadosGene-Jack WangGeorge F KoobNora D VolkowPublished in: Science advances (2021)
Individuals with alcohol use disorder (AUD) show elevated brain metabolism of acetate at the expense of glucose. We hypothesized that a shift in energy substrates during withdrawal may contribute to withdrawal severity and neurotoxicity in AUD and that a ketogenic diet (KD) may mitigate these effects. We found that inpatients with AUD randomized to receive KD (n = 19) required fewer benzodiazepines during the first week of detoxification, in comparison to those receiving a standard American (SA) diet (n = 14). Over a 3-week treatment, KD compared to SA showed lower "wanting" and increased dorsal anterior cingulate cortex (dACC) reactivity to alcohol cues and altered dACC bioenergetics (i.e., elevated ketones and glutamate and lower neuroinflammatory markers). In a rat model of alcohol dependence, a history of KD reduced alcohol consumption. We provide clinical and preclinical evidence for beneficial effects of KD on managing alcohol withdrawal and on reducing alcohol drinking.
Keyphrases
- alcohol consumption
- alcohol use disorder
- weight loss
- functional connectivity
- stem cells
- spinal cord
- clinical trial
- type diabetes
- randomized controlled trial
- placebo controlled
- skeletal muscle
- resting state
- adipose tissue
- blood pressure
- cell therapy
- bone marrow
- subarachnoid hemorrhage
- cerebral ischemia
- mesenchymal stem cells
- blood brain barrier
- depressive symptoms
- phase iii
- combination therapy
- phase ii
- glycemic control